APA (7th ed.) Citation

P, G., MP, D., AR, G., JC, F., T, M., KS, K., . . . P, K. (2013). Bioequivalence of oxycodone hydrochoride extended release tablets to marketed reference products OxyContin® in Canada and US. International journal of clinical pharmacology and therapeutics, 51(11), 895. https://doi.org/10.5414/CP201764

Chicago Style (17th ed.) Citation

P, Gosai, Ducharme MP, Godfrey AR, Freeman JC, Monif T, Kumar KS, Kumar S, Mudnaik R, and Katikaneni P. "Bioequivalence of Oxycodone Hydrochoride Extended Release Tablets to Marketed Reference Products OxyContin® in Canada and US." International Journal of Clinical Pharmacology and Therapeutics 51, no. 11 (2013): 895. https://doi.org/10.5414/CP201764.

MLA (9th ed.) Citation

P, Gosai, et al. "Bioequivalence of Oxycodone Hydrochoride Extended Release Tablets to Marketed Reference Products OxyContin® in Canada and US." International Journal of Clinical Pharmacology and Therapeutics, vol. 51, no. 11, 2013, p. 895, https://doi.org/10.5414/CP201764.